GT Biopharma, Inc. (GTBP)

0.6865 -0.04 (-5.96%) USD  |  NASDAQ  |  Jan 13, 13:34
More

GT Biopharma EPS Diluted from Discontinued Operations (Quarterly)

EPS Diluted from Discontinued Operations (Quarterly) Chart

View EPS Diluted from Discontinued Operations (Quarterly) for GTBP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Discontinued Operations (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Discontinued Operations (Quarterly) Range, Past 5 Years

View EPS Diluted from Discontinued Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Discontinued Operations (Quarterly) Benchmarks

View EPS Diluted from Discontinued Operations (Quarterly) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. --
SELLAS Life Sciences Group, Inc. --
Lyell Immunopharma, Inc. --
Plus Therapeutics, Inc. --
Geron Corp. --